Press Release

Mesirow Financial Advises The Flexan Corporation On Its Sale To Linden Capital Partners

CHICAGO, February 6, 2015 – Mesirow Financial acted as the exclusive financial advisor to The Flexan Corporation (“Flexan” or the “Company”) on its sale to Linden Capital Partners (“Linden”), a Chicago-based healthcare private equity firm.

Headquartered in Chicago, Illinois, the Company operates manufacturing facilities in the greater Chicago area and China under two distinct, but complementary business units, FMI, Inc. (“FMI”) and Flexan. FMI delivers clean room-manufactured silicone molded components for use in Class II disposable and Class III implantable medical devices. Flexan is a custom molder with expertise in molding difficult geometries, bonding rubber to metal and other substrates and delivering high precision, niche parts to a range of industries, including hearing technology, commercial and industrial.

Scott Severson, CEO of Flexan, commented, “Mesirow Financial’s expert guidance and unwavering support from start to finish was instrumental in securing a successful outcome for our shareholders and we are thrilled to have a partner like Linden who is committed to our continued growth.”

Jeff Golman, vice chairman and head of Mesirow Financial’s Investment Banking group said, “Mesirow Financial was honored to represent the owners of Flexan. We believe the Company’s unique expertise, coupled with its leading position in highly attractive end-markets, presents an exciting future.”

About Linden Capital Partners
Linden Capital Partners is a Chicago-based private equity firm focused exclusively on leveraged buyouts in the healthcare and life sciences industries. Linden's strategy is based upon three elements: i) healthcare and life science industry specialization, ii) integrated private equity and operating expertise, and iii) strategic relationships with large corporations. Linden invests in middle market platforms in the medical products, specialty distribution, pharmaceutical, and services segments of healthcare. For more information, please visit lindenllc.com.

Nothing contained herein constitutes an offer to sell or a solicitation of an offer to buy an interest in any Mesirow Financial investment vehicle(s). Mesirow Financial, Inc. is not affiliated with The Flexan Corporation, Linden Capital Partners or their affiliates. Past performance is not indicative of future results. Mesirow refers to Mesirow Financial Holdings, Inc. and its divisions, subsidiaries and affiliates. Securities offered through Mesirow Financial, Inc. member FINRA, SIPC.

Recent news

Experienced acquisitions expert Justin Maturo joins Mesirow Institutional Real Estate Direct Investments

Read article

Mesirow Advises Gelpac Inc. on its Sale to ProAmpac

Read article